Skip to content

Clinical trials

Phase 3 Cardiovascular Diseases trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 3 Country / region: Japan Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20071
20081
20091
20101
20111
20122
20141
20182
20191
20231
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting4
Active, not recruiting3
Terminated3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
GlaxoSmithKline3
Novartis Pharmaceuticals3
Alnylam Pharmaceuticals1
Amgen1
Boehringer Ingelheim1
CSL Behring1
Eli Lilly and Company1
Ethicon, Inc.1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases19
Atherosclerosis5
Stroke5
Heart Diseases4
Hypertension4
Acute Coronary Syndrome3
Diabetes Mellitus, Type 23
Myocardial Infarction3
Coronary Disease2
Atrial Fibrillation1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.